Multiple Endocrinology Immune-Related Adverse Events (irAEs) Related to Pembrolizumab as Neoadjuvant Treatment in Two Cases of TNBC Patients: Case Reports and Literature Review.
Simple Summary: irAEs can happen in any patient receiving ICIs, either in a metastatic or non-metastatic setting. Given their increasing application in clinical practice, understanding the underlying causes and manifestations, as well as diagnosis and management, is of great importance, making it on...
| Published in: | Current Oncology Vol. 31; no. 1; pp. 28 - 44 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Published: |
MDPI
Jan2026
|
| Online Access: | View this record in EBSCOhost |